,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.000193470725073262,0.107855027236563
2,WP_ZINC_HOMEOSTASIS,24,Up,0.000262102131802097,0.107855027236563
3,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.000511443241575738,0.140305929272278
4,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.000877355204415739,0.180515833308538
5,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Up,0.00191975773480647,0.315992123149144
6,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.00284245933100303,0.389890671569248
7,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.00418112772261452,0.491581159387393
8,WP_COMPLEMENT_AND_COAGULATION_CASCADES,31,Up,0.00615879619057406,0.514141689887696
9,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,31,Up,0.00615879619057406,0.514141689887696
10,WP_COPPER_HOMEOSTASIS,40,Up,0.00624716512621745,0.514141689887696
11,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.00863619490615239,0.554425708814698
12,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,23,Up,0.00914507165667523,0.554425708814698
13,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.0105400958807133,0.554425708814698
14,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,52,Up,0.0107318393444684,0.554425708814698
15,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Up,0.0109016714027963,0.554425708814698
16,WP_SMALL_LIGAND_GPCRS,7,Up,0.0111469570543055,0.554425708814698
17,WP_MEASLES_VIRUS_INFECTION,104,Up,0.0114522928916766,0.554425708814698
18,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.0136865609159577,0.559734848986734
19,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.0138772695469726,0.559734848986734
20,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Up,0.0142462730763759,0.559734848986734
21,WP_CREATINE_PATHWAY,3,Down,0.0142824202050078,0.559734848986734
22,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.0177025342765251,0.589532743429881
23,WP_IL10_ANTIINFLAMMATORY_SIGNALING,12,Up,0.0187269574309626,0.589532743429881
24,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.0190430760472142,0.589532743429881
25,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.0196665103289972,0.589532743429881
26,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,100,Up,0.019727212899653,0.589532743429881
27,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.0199594868312524,0.589532743429881
28,WP_PURINE_METABOLISM,10,Down,0.0200570070668732,0.589532743429881
29,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,31,Down,0.0222436022162654,0.599220622962545
30,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.0223691535086571,0.599220622962545
31,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.0247368707578813,0.599220622962545
32,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.0250463804635546,0.599220622962545
33,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.0255885019133365,0.599220622962545
34,WP_KALLMANN_SYNDROME,11,Up,0.0256412534455039,0.599220622962545
35,WP_COMPLEMENT_ACTIVATION,14,Up,0.0260330593307004,0.599220622962545
36,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.026289504125064,0.599220622962545
37,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.0279509182602165,0.599220622962545
38,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.0282925663990804,0.599220622962545
39,WP_BENZENE_METABOLISM,4,Up,0.028395630978784,0.599220622962545
40,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Up,0.029890538259177,0.614997824682566
41,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Up,0.0307584530120665,0.617419678754409
42,WP_DOPAMINE_METABOLISM,7,Up,0.0395733879927017,0.745187880558843
43,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.0426399839578583,0.745187880558843
44,WP_FERROPTOSIS,52,Up,0.0431162595012539,0.745187880558843
45,WP_KLEEFSTRA_SYNDROME,25,Down,0.0432866281642873,0.745187880558843
46,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.0450276443682616,0.745187880558843
47,WP_TOLLLIKE_RECEPTOR_SIGNALING,82,Up,0.0454139211000539,0.745187880558843
48,WP_PHOSPHOINOSITIDES_METABOLISM,39,Down,0.0462273699073567,0.745187880558843
49,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,75,Down,0.0480682690848535,0.745187880558843
50,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,30,Up,0.0484856790859205,0.745187880558843
51,WP_7OXOC_AND_7BETAHC_PATHWAYS,18,Up,0.0493480517947285,0.745187880558843
52,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Up,0.0497855951427835,0.745187880558843
53,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.0506854235729691,0.745187880558843
54,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.0506930889541482,0.745187880558843
55,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.0515465507212424,0.745187880558843
56,WP_IL7_SIGNALING,23,Up,0.0518429977657572,0.745187880558843
57,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.0526297193145622,0.745187880558843
58,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.0537809470559887,0.745187880558843
59,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.0542563973813762,0.745187880558843
60,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.0547622228175903,0.745187880558843
61,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.0552326375626846,0.745187880558843
62,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.0597738962267276,0.777204448347906
63,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.0600005814245261,0.777204448347906
64,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.0618065237932854,0.777204448347906
65,WP_FLUOROPYRIMIDINE_ACTIVITY,28,Up,0.0621646242575838,0.777204448347906
66,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Up,0.0634412301079307,0.777204448347906
67,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.0642571298219628,0.777204448347906
68,WP_LUNG_PATHOLOGY_OF_COVID19,17,Up,0.0654534961729239,0.777204448347906
69,WP_CHOLESTEROL_METABOLISM,53,Up,0.0662035378470901,0.777204448347906
70,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.0668641136584551,0.777204448347906
71,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.0679247015464698,0.777204448347906
72,WP_RETINOL_METABOLISM,7,Up,0.0682974481707223,0.777204448347906
73,WP_PANCREATIC_CANCER_SUBTYPES,6,Up,0.0689379401329249,0.777204448347906
74,WP_NRF2_PATHWAY,76,Up,0.0724082637044978,0.805297311200022
75,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Down,0.0752974876400881,0.826264431037233
76,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.0763356239593991,0.826634454191914
77,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.0793715517376375,0.840627143430943
78,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.0796706162668451,0.840627143430943
79,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Up,0.0855312209670219,0.840985955102714
80,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Up,0.0859566564241913,0.840985955102714
81,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.0877260895516186,0.840985955102714
82,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Up,0.088202388060791,0.840985955102714
83,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.089696141619878,0.840985955102714
84,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.0897341373629133,0.840985955102714
85,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Up,0.0900650322578207,0.840985955102714
86,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.0901960860825601,0.840985955102714
87,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.0925968398375631,0.840985955102714
88,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,21,Down,0.0928987494349686,0.840985955102714
89,WP_TGFB_SMAD_SIGNALING,8,Up,0.0930889637050987,0.840985955102714
90,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.0934030613989344,0.840985955102714
91,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Up,0.0934891707850823,0.840985955102714
92,WP_NRF2ARE_REGULATION,20,Up,0.0940105806433168,0.840985955102714
93,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,25,Down,0.0979735413413268,0.867013166923785
94,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Up,0.099139932527082,0.868001749678601
95,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Up,0.102292517913007,0.886176234130579
96,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.106060729924376,0.891471751161278
97,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.107080294021956,0.891471751161278
98,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.107174755412019,0.891471751161278
99,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,16,Down,0.107828747312306,0.891471751161278
100,WP_IL9_SIGNALING,15,Up,0.108924559919983,0.891471751161278
101,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.109402973107277,0.891471751161278
102,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,8,Up,0.113115768403394,0.910055732724882
103,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,17,Down,0.114576991125571,0.910055732724882
104,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.115884822840971,0.910055732724882
105,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Up,0.116106745973405,0.910055732724882
106,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,29,Down,0.118892071567211,0.923095989620894
107,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.120274302604776,0.92510047704421
108,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,49,Up,0.122637224416588,0.934541071248631
109,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.123950573604425,0.935883688774692
110,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.126147069572441,0.943809438710173
111,WP_PRION_DISEASE_PATHWAY,28,Up,0.127666651047929,0.94518976108842
112,WP_PPAR_SIGNALING,39,Up,0.128739774192844,0.94518976108842
113,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.130294428958097,0.94518976108842
114,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.132736084824829,0.94518976108842
115,WP_CORI_CYCLE,11,Down,0.133563173868368,0.94518976108842
116,WP_METABOLIC_EPILEPTIC_DISORDERS,59,Down,0.133602731436318,0.94518976108842
117,WP_SEROTONIN_AND_ANXIETY,7,Down,0.134702355214494,0.94518976108842
118,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.135946462241349,0.94518976108842
119,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.137672937225412,0.94518976108842
120,WP_CANCER_PATHWAYS,320,Up,0.13781624706028,0.94518976108842
121,WP_IRON_METABOLISM_DISORDERS,14,Up,0.139366104864224,0.947919870274848
122,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,46,Up,0.146765704577083,0.973847688958476
123,WP_G13_SIGNALING,30,Down,0.147547399914603,0.973847688958476
124,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.151625426083717,0.973847688958476
125,WP_IL2_SIGNALING,37,Up,0.151724519454199,0.973847688958476
126,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.156356547700433,0.973847688958476
127,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.156936683653031,0.973847688958476
128,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.157147380669698,0.973847688958476
129,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.157922720207778,0.973847688958476
130,WP_GPCRS_OTHER,17,Down,0.157966622852048,0.973847688958476
131,WP_KININKALLIKREIN_PATHWAY,3,Up,0.159513625927217,0.973847688958476
132,WP_PPARALPHA_PATHWAY,15,Up,0.160408139591274,0.973847688958476
133,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.163376744771599,0.973847688958476
134,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.164553084039697,0.973847688958476
135,WP_MICROTUBULE_CYTOSKELETON_REGULATION,36,Down,0.165042364357366,0.973847688958476
136,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.169534244108478,0.973847688958476
137,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.171269909314171,0.973847688958476
138,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.171413710228401,0.973847688958476
139,WP_AEROBIC_GLYCOLYSIS,10,Down,0.171486963926121,0.973847688958476
140,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.171486963926121,0.973847688958476
141,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.172459040182767,0.973847688958476
142,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,147,Up,0.175713368204896,0.973847688958476
143,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.17749291264842,0.973847688958476
144,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.177498724021835,0.973847688958476
145,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,14,Up,0.181678731838795,0.973847688958476
146,WP_OREXIN_RECEPTOR_PATHWAY,122,Down,0.182476604572093,0.973847688958476
147,WP_MATRIX_METALLOPROTEINASES,8,Up,0.184550463502142,0.973847688958476
148,WP_ENDOCHONDRAL_OSSIFICATION,27,Up,0.185899539768013,0.973847688958476
149,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Up,0.185899539768013,0.973847688958476
150,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.186851568720757,0.973847688958476
151,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Up,0.187897357231243,0.973847688958476
152,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.188858842861208,0.973847688958476
153,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.190109996580129,0.973847688958476
154,WP_BLOOD_CLOTTING_CASCADE,10,Up,0.190769602235971,0.973847688958476
155,WP_PEPTIDE_GPCRS,15,Up,0.190792689494719,0.973847688958476
156,WP_IRINOTECAN_PATHWAY,5,Up,0.193146015700513,0.973847688958476
157,WP_SMALL_CELL_LUNG_CANCER,73,Up,0.194992649846934,0.973847688958476
158,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.195463470328264,0.973847688958476
159,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.195943358898881,0.973847688958476
160,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Down,0.198032027111961,0.973847688958476
161,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.199708153237869,0.973847688958476
162,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Up,0.199783467724904,0.973847688958476
163,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.200388988784525,0.973847688958476
164,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.201637968623401,0.973847688958476
165,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.205407437220034,0.973847688958476
166,WP_SPINA_BIFIDA,10,Down,0.205596997805073,0.973847688958476
167,WP_VEGFAVEGFR2_SIGNALING,348,Up,0.2073990350455,0.973847688958476
168,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,16,Up,0.208464649343434,0.973847688958476
169,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,25,Up,0.210896256794924,0.973847688958476
170,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,11,Up,0.211050960817559,0.973847688958476
171,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.212436758840898,0.973847688958476
172,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.213711116233957,0.973847688958476
173,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.214161236225762,0.973847688958476
174,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.216661863297293,0.973847688958476
175,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,12,Down,0.218054699822975,0.973847688958476
176,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,15,Down,0.220912873644492,0.973847688958476
177,WP_GLUCURONIDATION,7,Up,0.222752413895954,0.973847688958476
178,WP_TRANSSULFURATION_PATHWAY,8,Down,0.222934805169951,0.973847688958476
179,WP_IL5_SIGNALING,37,Up,0.225855254824578,0.973847688958476
180,WP_TRYPTOPHAN_METABOLISM,19,Up,0.228293370242972,0.973847688958476
181,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,4,Up,0.228506168604086,0.973847688958476
182,WP_COMPLEMENT_SYSTEM,55,Up,0.228874637701237,0.973847688958476
183,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,75,Up,0.230626657746781,0.973847688958476
184,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Up,0.231056356189303,0.973847688958476
185,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,6,Down,0.231716248086708,0.973847688958476
186,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,42,Down,0.2339773388599,0.973847688958476
187,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.234843103551538,0.973847688958476
188,WP_ENDOTHELIN_PATHWAYS,13,Up,0.235936743612855,0.973847688958476
189,WP_ATR_SIGNALING,10,Up,0.235993213323215,0.973847688958476
190,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,66,Up,0.23649410202889,0.973847688958476
191,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.238294931333782,0.973847688958476
192,WP_HEME_BIOSYNTHESIS,8,Down,0.238294931333782,0.973847688958476
193,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,42,Up,0.238834799469155,0.973847688958476
194,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.240466230629183,0.973847688958476
195,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.24117117826061,0.973847688958476
196,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.243992860759086,0.973847688958476
197,WP_DNA_MISMATCH_REPAIR,21,Down,0.24426566649428,0.973847688958476
198,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,49,Down,0.244399592916582,0.973847688958476
199,WP_ASPIRIN_AND_MIRNAS,8,Down,0.244473604137063,0.973847688958476
200,WP_VITAMIN_B12_METABOLISM,27,Up,0.244787728711178,0.973847688958476
201,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Down,0.245388726221395,0.973847688958476
202,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,57,Up,0.250558103309841,0.973847688958476
203,WP_ESTROGEN_METABOLISM_WP5276,10,Up,0.250993033882851,0.973847688958476
204,WP_ESTROGEN_SIGNALING,21,Up,0.251588403154484,0.973847688958476
205,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.252536149481461,0.973847688958476
206,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,23,Up,0.25253717667894,0.973847688958476
207,WP_CAMKK2_PATHWAY,30,Up,0.252640791543096,0.973847688958476
208,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,13,Up,0.255969408179958,0.973847688958476
209,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.259279920376668,0.973847688958476
210,WP_LUNG_FIBROSIS,35,Up,0.260057923790789,0.973847688958476
211,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.260058301707439,0.973847688958476
212,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.260343471483631,0.973847688958476
213,WP_NEOVASCULARIZATION_PROCESSES,22,Up,0.263466930774497,0.973847688958476
214,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.264362972261415,0.973847688958476
215,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.266176802710015,0.973847688958476
216,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,27,Down,0.266226772193868,0.973847688958476
217,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.266899812621144,0.973847688958476
218,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.2694669539017,0.973847688958476
219,WP_FOXA2_PATHWAY,10,Down,0.273305253798627,0.973847688958476
220,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,20,Up,0.277685386552913,0.973847688958476
221,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,58,Up,0.279492388034289,0.973847688958476
222,WP_IL3_SIGNALING,46,Up,0.281372498567156,0.973847688958476
223,WP_INSULIN_SIGNALING,132,Down,0.282445623284835,0.973847688958476
224,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Up,0.283403945983671,0.973847688958476
225,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,11,Up,0.28425070488896,0.973847688958476
226,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.287163804114479,0.973847688958476
227,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.290061191527421,0.973847688958476
228,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.295252561031326,0.973847688958476
229,WP_NEPHROGENESIS,4,Down,0.29653708721559,0.973847688958476
230,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.298563880317834,0.973847688958476
231,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.299533424745291,0.973847688958476
232,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.299765170959351,0.973847688958476
233,WP_IL19_SIGNALING,20,Up,0.299854379575696,0.973847688958476
234,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,33,Down,0.30063821716433,0.973847688958476
235,WP_HOMOLOGOUS_RECOMBINATION,12,Down,0.30070875081604,0.973847688958476
236,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Up,0.300811890049892,0.973847688958476
237,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,42,Up,0.301294232954576,0.973847688958476
238,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.30470177608703,0.973847688958476
239,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,50,Down,0.30909180937757,0.973847688958476
240,WP_VITAMIN_A1_AND_A5X_PATHWAYS,4,Down,0.309730439298432,0.973847688958476
241,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Up,0.312035429133728,0.973847688958476
242,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.31458291908261,0.973847688958476
243,WP_IL11_SIGNALING,41,Up,0.314890198487743,0.973847688958476
244,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.314960203974025,0.973847688958476
245,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,22,Up,0.315862653941133,0.973847688958476
246,WP_GABA_RECEPTOR_SIGNALING,10,Down,0.318387558176602,0.973847688958476
247,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.319191871362247,0.973847688958476
248,WP_ENDOMETRIAL_CANCER,49,Up,0.320948168967432,0.973847688958476
249,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.321933665845017,0.973847688958476
250,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.323785112623396,0.973847688958476
251,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.32408389008129,0.973847688958476
252,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,19,Down,0.327079075077381,0.973847688958476
253,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,77,Up,0.328832004313935,0.973847688958476
254,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,64,Down,0.330252119065808,0.973847688958476
255,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,62,Down,0.330674821648408,0.973847688958476
256,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.331212540870261,0.973847688958476
257,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.33157118586658,0.973847688958476
258,WP_METHYLATION_PATHWAYS,5,Up,0.332366989611799,0.973847688958476
259,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,16,Up,0.335445402293421,0.973847688958476
260,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,90,Down,0.339603619190278,0.973847688958476
261,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.3402732346673,0.973847688958476
262,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,9,Up,0.340530232943671,0.973847688958476
263,WP_MRNA_PROCESSING,124,Down,0.342349538306622,0.973847688958476
264,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,22,Down,0.34238586539367,0.973847688958476
265,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.342872732070039,0.973847688958476
266,WP_CELLULAR_PROTEOSTASIS,6,Down,0.343095373713104,0.973847688958476
267,WP_MELANOMA,55,Up,0.343518957404726,0.973847688958476
268,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.345717091504245,0.973847688958476
269,WP_FOLATE_METABOLISM,40,Up,0.346420333634285,0.973847688958476
270,WP_IL18_SIGNALING,198,Up,0.346874173969644,0.973847688958476
271,WP_HYPERTROPHY_MODEL,14,Down,0.346901964519197,0.973847688958476
272,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.349740916457599,0.973847688958476
273,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.35035236025675,0.973847688958476
274,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.353142315727514,0.973847688958476
275,WP_16P112_DISTAL_DELETION_SYNDROME,24,Up,0.353792733372902,0.973847688958476
276,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.356880696086904,0.973847688958476
277,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.357309589075428,0.973847688958476
278,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.357843007605336,0.973847688958476
279,WP_NPHP1_DELETION_SYNDROME,10,Down,0.361812457792716,0.973847688958476
280,WP_CCL18_SIGNALING,22,Up,0.364317902335519,0.973847688958476
281,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.365789363925874,0.973847688958476
282,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,15,Up,0.367003512168973,0.973847688958476
283,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.367099230551948,0.973847688958476
284,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Up,0.367432145177398,0.973847688958476
285,WP_PYRIMIDINE_METABOLISM,75,Down,0.367873139965323,0.973847688958476
286,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Up,0.368657850797255,0.973847688958476
287,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,30,Down,0.371526767689337,0.973847688958476
288,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.37327695853387,0.973847688958476
289,WP_VALPROIC_ACID_PATHWAY,9,Down,0.374634791921142,0.973847688958476
290,WP_B_CELL_RECEPTOR_SIGNALING,88,Down,0.374745871857465,0.973847688958476
291,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.374806512012158,0.973847688958476
292,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Up,0.374952536624978,0.973847688958476
293,WP_ACUTE_MYELOID_LEUKEMIA,57,Up,0.377250022079447,0.973847688958476
294,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Up,0.378233017179488,0.973847688958476
295,WP_NRXN1_DELETION_SYNDROME,3,Down,0.379083540138077,0.973847688958476
296,WP_EBOLA_VIRUS_INFECTION_IN_HOST,109,Up,0.379817630525096,0.973847688958476
297,WP_BREAST_CANCER_PATHWAY,90,Up,0.380512454282386,0.973847688958476
298,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.381771444324972,0.973847688958476
299,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,14,Down,0.383976708977583,0.973847688958476
300,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.386371212689609,0.973847688958476
301,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,70,Down,0.387324482352415,0.973847688958476
302,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,38,Up,0.392384621503272,0.973847688958476
303,WP_PI3KAKT_SIGNALING,186,Up,0.393633096599347,0.973847688958476
304,WP_IDO_METABOLIC_PATHWAY,8,Down,0.394103539366425,0.973847688958476
305,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,10,Up,0.394683909533599,0.973847688958476
306,WP_HUNGER_AND_SATIETY,2,Up,0.395424518298819,0.973847688958476
307,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Up,0.397915023636823,0.973847688958476
308,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.398534402562146,0.973847688958476
309,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.399522021857291,0.973847688958476
310,WP_TCELL_ACTIVATION_SARSCOV2,64,Up,0.402591278734545,0.973847688958476
311,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.404267898160395,0.973847688958476
312,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.404877644738882,0.973847688958476
313,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.404877644738882,0.973847688958476
314,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.40612751326706,0.973847688958476
315,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.406215697457499,0.973847688958476
316,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.406718980898693,0.973847688958476
317,WP_MEVALONATE_PATHWAY,7,Up,0.407172118705012,0.973847688958476
318,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.410040468556053,0.973847688958476
319,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.410109587885589,0.973847688958476
320,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.415093244940471,0.973847688958476
321,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Down,0.417685945874608,0.973847688958476
322,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.41811268256556,0.973847688958476
323,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,49,Up,0.418439001755653,0.973847688958476
324,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,4,Up,0.419335455583583,0.973847688958476
325,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.419542317832967,0.973847688958476
326,WP_RAS_SIGNALING,121,Up,0.421487732620909,0.973847688958476
327,WP_BARDETBIEDL_SYNDROME,65,Up,0.422558024931234,0.973847688958476
328,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.426291553223986,0.973847688958476
329,WP_NUCLEAR_RECEPTORS_METAPATHWAY,184,Up,0.427236326560525,0.973847688958476
330,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.428101886009719,0.973847688958476
331,WP_ARYLAMINE_METABOLISM,1,Up,0.429067449249788,0.973847688958476
332,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.430052952946864,0.973847688958476
333,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.430829339842648,0.973847688958476
334,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.431316094645477,0.973847688958476
335,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,40,Up,0.431881119138429,0.973847688958476
336,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.432642342593776,0.973847688958476
337,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,88,Down,0.433143426659915,0.973847688958476
338,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.433218244111863,0.973847688958476
339,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.43622828281195,0.973847688958476
340,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.437294912814,0.973847688958476
341,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.437371687780218,0.973847688958476
342,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.437501975295084,0.973847688958476
343,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,9,Up,0.438046104015106,0.973847688958476
344,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.438588208648241,0.973847688958476
345,WP_PURINERGIC_SIGNALING,16,Up,0.43925507884585,0.973847688958476
346,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.439259215654258,0.973847688958476
347,WP_DISORDERS_IN_KETOLYSIS,4,Up,0.439305785867223,0.973847688958476
348,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.439357207984852,0.973847688958476
349,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.439357207984852,0.973847688958476
350,WP_HISTONE_MODIFICATIONS,37,Up,0.439526192525294,0.973847688958476
351,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.439604384530103,0.973847688958476
352,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,24,Up,0.441690475996969,0.973847688958476
353,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Up,0.442192864564832,0.973847688958476
354,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.443953750044882,0.973847688958476
355,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,64,Up,0.444251712764133,0.973847688958476
356,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.445698782439646,0.973847688958476
357,WP_DRAVET_SYNDROME,15,Down,0.44974520372758,0.973847688958476
358,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.450519152813846,0.973847688958476
359,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.451003729152986,0.973847688958476
360,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.452361849626242,0.973847688958476
361,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.453132623095389,0.973847688958476
362,WP_SPINAL_CORD_INJURY,69,Down,0.453612388460464,0.973847688958476
363,WP_MONOAMINE_TRANSPORT,12,Up,0.454775761732392,0.973847688958476
364,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.454871494096368,0.973847688958476
365,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,35,Up,0.455172000230163,0.973847688958476
366,WP_PRIMARY_OVARIAN_INSUFFICIENCY,95,Up,0.455589529784342,0.973847688958476
367,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.456048251472364,0.973847688958476
368,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.456473430489821,0.973847688958476
369,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.458871575850309,0.973847688958476
370,WP_VITAMIN_D_RECEPTOR_PATHWAY,86,Up,0.458890765480356,0.973847688958476
371,WP_FOXP3_IN_COVID19,10,Down,0.459979675729519,0.973847688958476
372,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Up,0.460118935739209,0.973847688958476
373,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,19,Up,0.460585757541053,0.973847688958476
374,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.461247945016769,0.973847688958476
375,WP_IL6_SIGNALING,40,Up,0.463945256199366,0.973847688958476
376,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.467430348477474,0.973847688958476
377,WP_GLUTATHIONE_METABOLISM,12,Up,0.467721921292424,0.973847688958476
378,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,171,Up,0.468615757699609,0.973847688958476
379,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.470992112366054,0.973847688958476
380,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.471219333695406,0.973847688958476
381,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.472801524055672,0.973847688958476
382,WP_MALE_INFERTILITY,70,Up,0.480355947413354,0.973847688958476
383,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.480389669614911,0.973847688958476
384,WP_BASE_EXCISION_REPAIR,29,Down,0.481395806829861,0.973847688958476
385,WP_NEURAL_CREST_DIFFERENTIATION,41,Down,0.481403250306683,0.973847688958476
386,WP_CYTOSOLIC_DNASENSING_PATHWAY,55,Up,0.481843899481892,0.973847688958476
387,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,20,Up,0.483685151285312,0.973847688958476
388,WP_PROLACTIN_SIGNALING,69,Down,0.48421577240824,0.973847688958476
389,WP_UROTENSINIIMEDIATED_SIGNALING,50,Up,0.484723269189577,0.973847688958476
390,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,2,Down,0.486349309347074,0.973847688958476
391,WP_ERBB_SIGNALING,69,Down,0.487212037660138,0.973847688958476
392,WP_EFFECTS_OF_MFN2_MUTATION,18,Down,0.490370597533938,0.973847688958476
393,WP_EGFEGFR_SIGNALING,143,Down,0.491163776843973,0.973847688958476
394,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,54,Up,0.491331050871787,0.973847688958476
395,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.491736503705596,0.973847688958476
396,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,16,Up,0.493988548582591,0.973847688958476
397,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.494076227320512,0.973847688958476
398,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.494226433296517,0.973847688958476
399,WP_NEUROINFLAMMATION,10,Down,0.494904072603577,0.973847688958476
400,WP_ECTODERM_DIFFERENTIATION,80,Up,0.499702056657764,0.973847688958476
401,WP_JOUBERT_SYNDROME,72,Up,0.499702201765496,0.973847688958476
402,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.499876035164723,0.973847688958476
403,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.500444981450693,0.973847688958476
404,WP_ENERGY_METABOLISM,41,Up,0.501168918513305,0.973847688958476
405,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.501455456139153,0.973847688958476
406,WP_NETRINUNC5B_SIGNALING,36,Up,0.504605280988319,0.973847688958476
407,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.504823006498718,0.973847688958476
408,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.504829251702829,0.973847688958476
409,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.504861645248312,0.973847688958476
410,WP_PROTEASOME_DEGRADATION,57,Up,0.508610672561642,0.973847688958476
411,WP_NUCLEAR_RECEPTORS,21,Down,0.509268280515376,0.973847688958476
412,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.511146270028603,0.973847688958476
413,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.511894496721564,0.973847688958476
414,WP_KIT_RECEPTOR_SIGNALING,53,Down,0.513493833330409,0.973847688958476
415,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,33,Up,0.514462323086272,0.973847688958476
416,WP_AGERAGE_PATHWAY,54,Up,0.514974094630788,0.973847688958476
417,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.517848330721456,0.973847688958476
418,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,13,Up,0.520508713853172,0.973847688958476
419,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.521738378728488,0.973847688958476
420,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,51,Up,0.523835410908127,0.973847688958476
421,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.526451203335719,0.973847688958476
422,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Up,0.526951676073464,0.973847688958476
423,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.528553568318131,0.973847688958476
424,WP_RAC1PAK1P38MMP2_PATHWAY,53,Up,0.528562683654889,0.973847688958476
425,WP_NONSMALL_CELL_LUNG_CANCER,61,Up,0.528709785072939,0.973847688958476
426,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.533353212099361,0.973847688958476
427,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.533410284527944,0.973847688958476
428,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.533866123577031,0.973847688958476
429,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.537156418569605,0.973847688958476
430,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.537156418569605,0.973847688958476
431,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,14,Down,0.537622033105597,0.973847688958476
432,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.538096753699076,0.973847688958476
433,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Up,0.53816299770762,0.973847688958476
434,WP_CHOLESTASIS,9,Up,0.539844537863143,0.973847688958476
435,WP_NOTCH_SIGNALING_WP268,36,Down,0.540684823837483,0.973847688958476
436,WP_OXIDATIVE_DAMAGE_RESPONSE,36,Up,0.540721105940701,0.973847688958476
437,WP_ACUTE_VIRAL_MYOCARDITIS,69,Up,0.541105621169833,0.973847688958476
438,WP_DNA_DAMAGE_RESPONSE,60,Up,0.542619650658313,0.973847688958476
439,WP_CYTOSINE_METHYLATION,7,Down,0.542649069731849,0.973847688958476
440,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Up,0.543901680023897,0.973847688958476
441,WP_PREGNANE_X_RECEPTOR_PATHWAY,14,Up,0.544099097020801,0.973847688958476
442,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.544984356844108,0.973847688958476
443,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,34,Up,0.548399184242644,0.973847688958476
444,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.549094934665135,0.973847688958476
445,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Down,0.549665199376084,0.973847688958476
446,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.552406146579807,0.973847688958476
447,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.553396954260163,0.973847688958476
448,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,26,Up,0.554196809912546,0.973847688958476
449,WP_APOPTOSIS_MODULATION_AND_SIGNALING,80,Up,0.55530492662496,0.973847688958476
450,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.558424820365103,0.973847688958476
451,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.559185335420943,0.973847688958476
452,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Down,0.560338622934284,0.973847688958476
453,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.560743945307686,0.973847688958476
454,WP_ID_SIGNALING,12,Down,0.562571300869586,0.973847688958476
455,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.563718967611819,0.973847688958476
456,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,45,Up,0.566217159976401,0.973847688958476
457,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.569987819605386,0.973847688958476
458,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,74,Up,0.571317929279246,0.973847688958476
459,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,17,Up,0.57147832359897,0.973847688958476
460,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.572092430312629,0.973847688958476
461,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.572462733543822,0.973847688958476
462,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,130,Down,0.572567493364113,0.973847688958476
463,WP_IL4_SIGNALING,51,Down,0.574607372887866,0.973847688958476
464,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Down,0.576448366399541,0.973847688958476
465,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.57684098907185,0.973847688958476
466,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.576956519631592,0.973847688958476
467,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,40,Down,0.577149650565553,0.973847688958476
468,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,88,Down,0.578406339047782,0.973847688958476
469,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.578422856748931,0.973847688958476
470,WP_GPR40_PATHWAY,10,Down,0.579045131052911,0.973847688958476
471,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.581067334776827,0.973847688958476
472,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.581140511498232,0.973847688958476
473,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,19,Up,0.581877473050152,0.973847688958476
474,WP_CHEMOKINE_SIGNALING,111,Up,0.585817048619625,0.973847688958476
475,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,12,Down,0.586027134355785,0.973847688958476
476,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,28,Down,0.586790702051461,0.973847688958476
477,WP_SELENIUM_MICRONUTRIENT_NETWORK,53,Up,0.587534560949448,0.973847688958476
478,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.590625336842857,0.973847688958476
479,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,23,Down,0.590830836477698,0.973847688958476
480,WP_ALZHEIMERS_DISEASE,187,Up,0.591839344578043,0.973847688958476
481,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,187,Up,0.591839344578043,0.973847688958476
482,WP_OVARIAN_INFERTILITY,23,Up,0.592471972628579,0.973847688958476
483,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,32,Up,0.593520870077648,0.973847688958476
484,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Down,0.594336942953043,0.973847688958476
485,WP_CILIOPATHIES,129,Up,0.595586575861875,0.973847688958476
486,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.596208114651793,0.973847688958476
487,WP_TRANSLATION_FACTORS,49,Up,0.597745130499426,0.973847688958476
488,WP_AFLATOXIN_B1_METABOLISM,3,Up,0.598141695593767,0.973847688958476
489,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,85,Up,0.598677894023629,0.973847688958476
490,WP_THERMOGENESIS,75,Up,0.599433882399686,0.973847688958476
491,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.600461816300663,0.973847688958476
492,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.601590635135353,0.973847688958476
493,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,4,Down,0.601740387220435,0.973847688958476
494,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,14,Down,0.604181473045567,0.973847688958476
495,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.605392218888176,0.973847688958476
496,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,17,Up,0.605677942479428,0.973847688958476
497,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,16,Up,0.60604231032001,0.973847688958476
498,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.607588359966129,0.973847688958476
499,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.609219664075995,0.973847688958476
500,WP_IL26_SIGNALING,33,Up,0.609749027995941,0.973847688958476
501,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.609873275758961,0.973847688958476
502,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,51,Down,0.610694261839908,0.973847688958476
503,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.610819797848239,0.973847688958476
504,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,41,Up,0.611203153391417,0.973847688958476
505,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,280,Up,0.611408889529069,0.973847688958476
506,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.611819469303435,0.973847688958476
507,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Up,0.612474065807014,0.973847688958476
508,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.612841616067947,0.973847688958476
509,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.613011415814551,0.973847688958476
510,WP_DNA_REPLICATION,37,Down,0.613458711717773,0.973847688958476
511,WP_FOCAL_ADHESION,123,Up,0.613624958383288,0.973847688958476
512,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,8,Down,0.614341837397914,0.973847688958476
513,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.616710198786722,0.973847688958476
514,WP_SULFATASE_AND_AROMATASE_PATHWAY,4,Up,0.616947301711123,0.973847688958476
515,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,22,Up,0.618084680901197,0.973847688958476
516,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Down,0.618793861054201,0.973847688958476
517,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.620502495437612,0.973847688958476
518,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,78,Up,0.622457484648784,0.973847688958476
519,WP_ANGIOGENESIS,15,Up,0.623204983597961,0.973847688958476
520,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,44,Up,0.624557068114652,0.973847688958476
521,WP_MONOAMINE_GPCRS,3,Down,0.624599019072643,0.973847688958476
522,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.625216247915825,0.973847688958476
523,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Up,0.628022103857491,0.973847688958476
524,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.62823425302531,0.973847688958476
525,WP_WNT_SIGNALING_WP428,61,Down,0.629364693080653,0.973847688958476
526,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Down,0.632155497550921,0.973847688958476
527,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.632987618454991,0.973847688958476
528,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.633988292017598,0.973847688958476
529,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.63439142046,0.973847688958476
530,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,81,Up,0.636255592865595,0.973847688958476
531,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,54,Up,0.636538484747547,0.973847688958476
532,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.638473591789417,0.973847688958476
533,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.639135465788614,0.973847688958476
534,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.639806255587179,0.973847688958476
535,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,81,Up,0.640036425556722,0.973847688958476
536,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Down,0.642517399906294,0.973847688958476
537,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.642795359822375,0.973847688958476
538,WP_MIRNA_BIOGENESIS,6,Up,0.6429223744771,0.973847688958476
539,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,14,Up,0.644607748773984,0.973847688958476
540,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.647366950112068,0.973847688958476
541,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Up,0.647431621573998,0.973847688958476
542,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Up,0.64755373372191,0.973847688958476
543,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.648412453393119,0.973847688958476
544,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,27,Down,0.64892986579073,0.973847688958476
545,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.649028842190433,0.973847688958476
546,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,25,Up,0.650396302085501,0.973847688958476
547,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.651159381088407,0.973847688958476
548,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.6520750336395,0.973847688958476
549,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.6528208807504,0.973847688958476
550,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.654237835625257,0.973847688958476
551,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.656895819244599,0.973847688958476
552,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.659302558846721,0.973847688958476
553,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,23,Up,0.660967653860576,0.973847688958476
554,WP_POSTCOVID_NEUROINFLAMMATION,14,Down,0.662475597299402,0.973847688958476
555,WP_TLR4_SIGNALING_AND_TOLERANCE,27,Up,0.66276557675164,0.973847688958476
556,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.662923517028489,0.973847688958476
557,WP_ALLOGRAFT_REJECTION,53,Up,0.663638329931911,0.973847688958476
558,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.663819098084637,0.973847688958476
559,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.664098893088966,0.973847688958476
560,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.664099283564374,0.973847688958476
561,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.667105674120071,0.973847688958476
562,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.669473550882986,0.973847688958476
563,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.66949107414273,0.973847688958476
564,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,182,Down,0.672031475877016,0.973847688958476
565,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Up,0.672622040239556,0.973847688958476
566,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,50,Up,0.67440073334567,0.973847688958476
567,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.675642948458818,0.973847688958476
568,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,25,Up,0.677952574321559,0.973847688958476
569,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Up,0.678474772374418,0.973847688958476
570,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.678572208024067,0.973847688958476
571,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.678655320429608,0.973847688958476
572,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Up,0.679264011376766,0.973847688958476
573,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.681097230517713,0.973847688958476
574,WP_TNFALPHA_SIGNALING,86,Up,0.683113840246301,0.973847688958476
575,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.684557475368938,0.973847688958476
576,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,21,Down,0.684701038230906,0.973847688958476
577,WP_HIPPOYAP_SIGNALING,16,Down,0.68635036981224,0.973847688958476
578,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.687630096436364,0.973847688958476
579,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.68821951830217,0.973847688958476
580,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.688236249897359,0.973847688958476
581,WP_IL17_SIGNALING,25,Up,0.69421471588656,0.973847688958476
582,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.695734020441746,0.973847688958476
583,WP_RANKLRANK_SIGNALING,49,Up,0.702867479030579,0.973847688958476
584,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.703547883753807,0.973847688958476
585,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.704790435432803,0.973847688958476
586,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.705095571705141,0.973847688958476
587,WP_KREBS_CYCLE_DISORDERS,11,Up,0.708454406660009,0.973847688958476
588,WP_TAMOXIFEN_METABOLISM,2,Up,0.709290388116219,0.973847688958476
589,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Up,0.71189689296348,0.973847688958476
590,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Up,0.712222690889996,0.973847688958476
591,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.712979330604684,0.973847688958476
592,WP_BENZOAPYRENE_METABOLISM,5,Up,0.713592898081082,0.973847688958476
593,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,55,Down,0.713760935463106,0.973847688958476
594,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.715710254555245,0.973847688958476
595,WP_INTEGRATED_CANCER_PATHWAY,41,Up,0.716999764311325,0.973847688958476
596,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,50,Up,0.717319301545316,0.973847688958476
597,WP_HEPATITIS_B_INFECTION,121,Up,0.717559462013106,0.973847688958476
598,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.71756324624948,0.973847688958476
599,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Up,0.717978783924147,0.973847688958476
600,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.718311446971484,0.973847688958476
601,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.718366612156068,0.973847688958476
602,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.718506159241091,0.973847688958476
603,WP_CIRCADIAN_RHYTHM_GENES,124,Up,0.719039324458571,0.973847688958476
604,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,36,Up,0.71972024742686,0.973847688958476
605,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.719950889039852,0.973847688958476
606,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,128,Up,0.721544473710519,0.973847688958476
607,WP_GASTRIN_SIGNALING,95,Down,0.721568727570104,0.973847688958476
608,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.722614549386959,0.973847688958476
609,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.723698902011917,0.973847688958476
610,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.723915026580543,0.973847688958476
611,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.724373947735045,0.973847688958476
612,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.725567666367288,0.973847688958476
613,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,42,Down,0.727924103965273,0.973847688958476
614,WP_HIPPO_SIGNALING_REGULATION,46,Up,0.729705401613224,0.973847688958476
615,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.730903483590174,0.973847688958476
616,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Down,0.731136403724166,0.973847688958476
617,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Up,0.732134688784394,0.973847688958476
618,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.734404824351603,0.973847688958476
619,WP_NAD_METABOLISM,12,Down,0.735041052226834,0.973847688958476
620,WP_13Q1212_COPY_NUMBER_VARIATION,21,Up,0.735076279136386,0.973847688958476
621,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.735594088585136,0.973847688958476
622,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.736006394328277,0.973847688958476
623,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.745668992711555,0.982268876542926
624,WP_GALANIN_RECEPTOR_PATHWAY,12,Down,0.745758948842346,0.982268876542926
625,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Down,0.74811145222176,0.982268876542926
626,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.750149715008407,0.982268876542926
627,WP_ALSTROM_SYNDROME,27,Up,0.753152065198802,0.982268876542926
628,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.758342025416647,0.982268876542926
629,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.758711119377785,0.982268876542926
630,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.759150457664104,0.982268876542926
631,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,50,Up,0.759531127157597,0.982268876542926
632,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.761607597677491,0.982268876542926
633,WP_AMINO_ACID_METABOLISM,60,Up,0.762141131090492,0.982268876542926
634,WP_RETT_SYNDROME,32,Down,0.763260024179028,0.982268876542926
635,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.766095129088286,0.982268876542926
636,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.766266639747007,0.982268876542926
637,WP_RETINOBLASTOMA_GENE_IN_CANCER,76,Down,0.7663613690472,0.982268876542926
638,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,61,Up,0.767341025469606,0.982268876542926
639,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,35,Down,0.770932479468321,0.982268876542926
640,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,31,Down,0.771180208112793,0.982268876542926
641,WP_SPHINGOLIPID_PATHWAY,21,Down,0.772438880677141,0.982268876542926
642,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,10,Up,0.77308401842827,0.982268876542926
643,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Up,0.774853845459528,0.982268876542926
644,WP_OXIDATION_BY_CYTOCHROME_P450,16,Up,0.778682064661531,0.982268876542926
645,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.778738190110703,0.982268876542926
646,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.779165898664277,0.982268876542926
647,WP_GLIOBLASTOMA_SIGNALING,70,Down,0.780163446712631,0.982268876542926
648,WP_VITAMIN_B12_DISORDERS,9,Up,0.781522364294948,0.982268876542926
649,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.783408417192806,0.982268876542926
650,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.783981992266022,0.982268876542926
651,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.784367136769595,0.982268876542926
652,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.786847905397541,0.982268876542926
653,WP_MTHFR_DEFICIENCY,18,Down,0.787706278970011,0.982268876542926
654,WP_BLADDER_CANCER,29,Down,0.792685044331325,0.982268876542926
655,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,21,Up,0.793458873482741,0.982268876542926
656,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Down,0.794497702932063,0.982268876542926
657,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,39,Up,0.795434474055336,0.982268876542926
658,WP_OSTEOPONTIN_SIGNALING,11,Up,0.795701038186163,0.982268876542926
659,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,50,Down,0.796494819007662,0.982268876542926
660,WP_HEART_DEVELOPMENT,19,Up,0.801155776882027,0.982268876542926
661,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,67,Down,0.803390762827531,0.982268876542926
662,WP_ADIPOGENESIS,88,Down,0.804469403189292,0.982268876542926
663,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Down,0.80612600818428,0.982268876542926
664,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,94,Up,0.807253725261301,0.982268876542926
665,WP_APOPTOSIS,74,Up,0.807880364616852,0.982268876542926
666,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.807972958729454,0.982268876542926
667,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.808556182912145,0.982268876542926
668,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Down,0.80888585412338,0.982268876542926
669,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Down,0.809528355975063,0.982268876542926
670,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.810717332228444,0.982268876542926
671,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.811520025449154,0.982268876542926
672,WP_PROSTAGLANDIN_SIGNALING,23,Up,0.811528060836041,0.982268876542926
673,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.812139023536698,0.982268876542926
674,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.812309369605782,0.982268876542926
675,WP_IRON_METABOLISM_IN_PLACENTA,10,Down,0.812386929605425,0.982268876542926
676,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,107,Down,0.812485433653041,0.982268876542926
677,WP_KCNQ2RELATED_EPILEPSIES,12,Down,0.812553947602085,0.982268876542926
678,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.816538432060958,0.982268876542926
679,WP_TAR_SYNDROME,46,Up,0.819694864872772,0.982268876542926
680,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.819800573340545,0.982268876542926
681,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.819973224361974,0.982268876542926
682,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.820584876540723,0.982268876542926
683,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.821272607148743,0.982268876542926
684,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,14,Up,0.821563208825884,0.982268876542926
685,WP_TGFBETA_RECEPTOR_SIGNALING,37,Up,0.821921723802233,0.982268876542926
686,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.822486044153794,0.982268876542926
687,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.824963476422657,0.982268876542926
688,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.829835273580043,0.982268876542926
689,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.832925618895588,0.982268876542926
690,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.833066858260901,0.982268876542926
691,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.833864472397516,0.982268876542926
692,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.834152669818114,0.982268876542926
693,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,12,Up,0.834157668839977,0.982268876542926
694,WP_15Q25_COPY_NUMBER_VARIATION,29,Up,0.835175780381223,0.982268876542926
695,WP_OSTEOCLAST_SIGNALING,9,Down,0.836844599886772,0.982268876542926
696,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.838463180723948,0.982268876542926
697,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,71,Up,0.839360107012929,0.982268876542926
698,WP_ENDODERM_DIFFERENTIATION,85,Down,0.840469558888244,0.982268876542926
699,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.840932285528627,0.982268876542926
700,WP_PREIMPLANTATION_EMBRYO,22,Up,0.842470104376962,0.982268876542926
701,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.842623054456561,0.982268876542926
702,WP_OSTEOBLAST_SIGNALING,3,Up,0.842840148115157,0.982268876542926
703,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Down,0.843279440155857,0.982268876542926
704,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.843795170716083,0.982268876542926
705,WP_NEPHROTIC_SYNDROME,29,Up,0.844337082068371,0.982268876542926
706,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.844889690116541,0.982268876542926
707,WP_G_PROTEIN_SIGNALING,62,Up,0.845969471467051,0.982268876542926
708,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.84755403558283,0.982268876542926
709,WP_CELL_CYCLE,100,Down,0.847868440176301,0.982268876542926
710,WP_GLYOXYLATE_METABOLISM,5,Down,0.848121358620962,0.982268876542926
711,WP_IL1_SIGNALING,54,Down,0.84859437572542,0.982268876542926
712,WP_SERINE_METABOLISM,7,Down,0.850482419450538,0.98274927985577
713,WP_FRAGILE_X_SYNDROME,86,Down,0.851482335233337,0.98274927985577
714,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.852631646871889,0.98274927985577
715,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.853785826363154,0.98274927985577
716,WP_AUTOPHAGY,27,Down,0.85930108859812,0.983357368386625
717,WP_AXON_GUIDANCE,39,Down,0.860084660739543,0.983357368386625
718,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Up,0.860455258643618,0.983357368386625
719,WP_OPIOID_RECEPTOR_PATHWAYS,26,Down,0.861424615083925,0.983357368386625
720,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Up,0.863044137404479,0.983357368386625
721,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,41,Down,0.863681328872117,0.983357368386625
722,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.864378630863805,0.983357368386625
723,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.865532019931103,0.983357368386625
724,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.867041188124403,0.983357368386625
725,WP_NOTCH_SIGNALING_WP61,50,Down,0.867127226792512,0.983357368386625
726,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.867831182396356,0.983357368386625
727,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.868652256156836,0.983357368386625
728,WP_WNT_SIGNALING_WP363,39,Up,0.871489155963137,0.98357385615749
729,WP_NUCLEOTIDE_GPCRS,6,Up,0.871907380213595,0.98357385615749
730,WP_PLEURAL_MESOTHELIOMA,262,Down,0.873270655941683,0.98357385615749
731,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.874910007353707,0.98357385615749
732,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Up,0.875203252010714,0.98357385615749
733,WP_MAPK_SIGNALING,166,Up,0.876014139202236,0.98357385615749
734,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.878794836285645,0.985351703355703
735,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.881412552724362,0.98641028166264
736,WP_PDGFRBETA_PATHWAY,28,Up,0.882136047756626,0.98641028166264
737,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,79,Down,0.884817442013792,0.987000575751207
738,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,16,Up,0.886262035582718,0.987000575751207
739,WP_SLEEP_REGULATION,11,Down,0.887343144058344,0.987000575751207
740,WP_ATM_SIGNALING,35,Up,0.887461028014451,0.987000575751207
741,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.893415807576674,0.988997351597949
742,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,46,Down,0.893484717388153,0.988997351597949
743,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Up,0.897537451062155,0.988997351597949
744,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,14,Down,0.8978589357639,0.988997351597949
745,WP_ALPHA_6_BETA_4_SIGNALING,27,Up,0.897899111296221,0.988997351597949
746,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.898428740617966,0.988997351597949
747,WP_ONCOSTATIN_M_SIGNALING,56,Up,0.898768274482925,0.988997351597949
748,WP_4P163_COPY_NUMBER_VARIATION,22,Up,0.899908047639283,0.988997351597949
749,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.900071708805424,0.988997351597949
750,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.90217189950741,0.989375185236667
751,WP_SILDENAFIL_TREATMENT,12,Up,0.903331493137841,0.989375185236667
752,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.907622694188099,0.989375185236667
753,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,19,Up,0.909366047156923,0.989375185236667
754,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,67,Up,0.910699033608499,0.989375185236667
755,WP_MAPK_CASCADE,30,Down,0.910894811055305,0.989375185236667
756,WP_ULCERATIVE_COLITIS_SIGNALING,13,Down,0.913314179680816,0.989375185236667
757,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Down,0.915006512378415,0.989375185236667
758,WP_P38_MAPK_SIGNALING,31,Down,0.918171997547985,0.989375185236667
759,WP_SYNAPTIC_VESICLE_PATHWAY,24,Down,0.918853319620262,0.989375185236667
760,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.918954742776457,0.989375185236667
761,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.919085689504777,0.989375185236667
762,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,34,Down,0.919631258546241,0.989375185236667
763,WP_ONECARBON_METABOLISM,23,Up,0.920460384527705,0.989375185236667
764,WP_TCELL_RECEPTOR_SIGNALING,76,Down,0.920864898627195,0.989375185236667
765,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.920934388175354,0.989375185236667
766,WP_MACROPHAGE_MARKERS,9,Down,0.921961518446493,0.989375185236667
767,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,12,Down,0.922054394989701,0.989375185236667
768,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.924820241657891,0.991050857922454
769,WP_GPCRS_CLASS_A_RHODOPSINLIKE,46,Up,0.929350644731691,0.994505301198728
770,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,33,Down,0.930651672560831,0.994505301198728
771,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.933624385078889,0.994505301198728
772,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.934234327458111,0.994505301198728
773,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Up,0.935600280292448,0.994505301198728
774,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,63,Down,0.935970137988365,0.994505301198728
775,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.936502561882156,0.994505301198728
776,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.945014381415018,0.999377366029884
777,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.946303135598035,0.999377366029884
778,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.946812134513719,0.999377366029884
779,WP_PDGF_PATHWAY,37,Down,0.949672830421701,0.999377366029884
780,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.950573254861605,0.999377366029884
781,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.950925772054438,0.999377366029884
782,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,34,Up,0.951789081489279,0.999377366029884
783,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Down,0.952106621213043,0.999377366029884
784,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.953515907802463,0.999377366029884
785,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.955272875294255,0.999377366029884
786,WP_5Q35_COPY_NUMBER_VARIATION,78,Down,0.958230589549031,0.999377366029884
787,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,10,Up,0.960040681419888,0.999377366029884
788,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.961744081000392,0.999377366029884
789,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,38,Up,0.962544477083045,0.999377366029884
790,WP_TP53_NETWORK,16,Down,0.962632337787594,0.999377366029884
791,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.962648298173235,0.999377366029884
792,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.963536997693788,0.999377366029884
793,WP_STEROID_BIOSYNTHESIS,3,Up,0.96355007359364,0.999377366029884
794,WP_CILIARY_LANDSCAPE,186,Up,0.964793418081518,0.999377366029884
795,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1,Down,0.967340032666439,0.999377366029884
796,WP_BURN_WOUND_HEALING,63,Up,0.968764992658547,0.999377366029884
797,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.968943704825191,0.999377366029884
798,WP_VITAMIN_D_METABOLISM,6,Down,0.971770791067321,0.999377366029884
799,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.973464286743852,0.999377366029884
800,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Up,0.974708639442696,0.999377366029884
801,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,114,Down,0.975132194105705,0.999377366029884
802,WP_EICOSANOID_SYNTHESIS,14,Down,0.975696566828032,0.999377366029884
803,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Down,0.976089644583583,0.999377366029884
804,WP_ESTROGEN_METABOLISM_WP697,6,Down,0.976305470580834,0.999377366029884
805,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.977711300941949,0.999573168540651
806,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Down,0.980921840039224,0.999803660888678
807,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.98146354151856,0.999803660888678
808,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.9823562957887,0.999803660888678
809,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Up,0.984246610024513,0.999803660888678
810,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.985535340929536,0.999803660888678
811,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,16,Down,0.985615618582906,0.999803660888678
812,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.98666133324187,0.999803660888678
813,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.987711164882853,0.999803660888678
814,WP_MESODERMAL_COMMITMENT_PATHWAY,79,Down,0.990975141283745,0.999803660888678
815,WP_LEPTIN_SIGNALING,70,Up,0.992940373614644,0.999803660888678
816,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.994015394649695,0.999803660888678
817,WP_FTO_OBESITY_VARIANT_MECHANISM,3,Down,0.996879467531203,0.999803660888678
818,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,31,Up,0.997441567966481,0.999803660888678
819,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.997806051772128,0.999803660888678
820,WP_BDNFTRKB_SIGNALING,27,Up,0.998387649898925,0.999803660888678
821,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.998578815466946,0.999803660888678
822,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Up,0.998971381913333,0.999803660888678
823,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,22,Down,0.999803660888678,0.999803660888678
